NanoViricides, Inc. (NYSE American: NNVC) has filed its quarterly report for the period ending Dec. 31, 2024, with the SEC, reporting cash and cash e ...

The company said, “We reported that, as of December 31, 2024, we had cash and cash equivalent current assets balance of approximately $3.96 ...

Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu ...

(NNVC) on Friday reported a loss of $2 million in its fiscal second quarter. On a per-share basis, the Shelton, Connecticut-based company said it had a loss of 14 cents. This story was generated by ...

We recently published a list of 7 Best Nanotech Penny Stocks to Invest In. In this article, we are going to take a look at ...

Shelton, Connecticut Thursday, February 13, 2025, 16:00 Hrs [IST] ...

Applied DNA Sciences, Inc. (NASDAQ:APDN) (”Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today issued a reminder to its shareholders to vote ahead of a reconvening of a ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company") declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

(MENAFN- Investor Brand Network) NanoViricides, Inc. (NYSE American: NNVC) announced its broad-spectrum antiviral NV-387 as a potential solution for combating H5N1 bird flu, stating that the virus is ...

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.